| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,091,094 | 675,052 | 587,420 | 1,650,285 | | Cost of Revenue | 1,092,748 | 612,848 | 1,022,249 | 2,117,910 | | | Gross Profit | (1,654) | 62,204 | (434,829) | (467,625) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 264,459 | 271,301 | 26,896 |
-
| | Non Recurring | 19,412 | (19,412) |
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (285,525) | (189,685) | (461,725) | (467,625) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (68,593) | 6,175 |
-
| 713 | | Earnings Before Interest And Taxes | (358,288) | (186,015) | (512,246) | (479,725) | | Interest Expense | 431 | 914 |
-
|
-
| | Income Before Tax | (358,719) | (186,929) | (512,246) | (479,725) | | Income Tax Expense | 2,668 | 2,536 | 2,572 | (141,560) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (418,583) | (189,465) | (514,818) | (338,165) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (361,387) | (189,465) | (514,818) | (338,165) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($361,387) | ($189,465) | ($514,818) | ($338,165) |
|
0.01% Nasdaq 
0.22%
Income Statement
